Deutsche Bank analysts reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) on February 09, 2026.
Eli Lilly and Company operates in the Healthcare sector. The stock currently trades at $1044.67 with a market capitalization of $906.5B. The stock has gained 24.2% over the past 52 weeks.


